259 related articles for article (PubMed ID: 31644574)
1. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
Eraña H; Charco JM; Di Bari MA; Díaz-Domínguez CM; López-Moreno R; Vidal E; González-Miranda E; Pérez-Castro MA; García-Martínez S; Bravo S; Fernández-Borges N; Geijo M; D'Agostino C; Garrido J; Bian J; König A; Uluca-Yazgi B; Sabate R; Khaychuk V; Vanni I; Telling GC; Heise H; Nonno R; Requena JR; Castilla J
PLoS Pathog; 2019 Oct; 15(10):e1008117. PubMed ID: 31644574
[TBL] [Abstract][Full Text] [Related]
2. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
3. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.
Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D
Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091
[TBL] [Abstract][Full Text] [Related]
4.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
5. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
6. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
7. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon protects neurons from prions in in vivo models.
Ishibashi D; Homma T; Nakagaki T; Fuse T; Sano K; Satoh K; Mori T; Atarashi R; Nishida N
Brain; 2019 Apr; 142(4):1035-1050. PubMed ID: 30753318
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
Ma J; Zhang J; Yan R
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
[TBL] [Abstract][Full Text] [Related]
11. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Bidirectional Properties of the Sheep-Deer Prion Transmission Barrier.
Harrathi C; Fernández-Borges N; Eraña H; Elezgarai SR; Venegas V; Charco JM; Castilla J
Mol Neurobiol; 2019 Aug; 56(8):5287-5303. PubMed ID: 30592012
[TBL] [Abstract][Full Text] [Related]
13.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
14. Essential Components of Synthetic Infectious Prion Formation De Novo.
Jack K; Jackson GS; Bieschke J
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421708
[TBL] [Abstract][Full Text] [Related]
15. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
[TBL] [Abstract][Full Text] [Related]
16. Design, implementation, and interpretation of amplification studies for prion detection.
Haley NJ; Richt JA; Davenport KA; Henderson DM; Hoover EA; Manca M; Caughey B; Marthaler D; Bartz J; Gilch S
Prion; 2018 Mar; 12(2):73-82. PubMed ID: 29468946
[TBL] [Abstract][Full Text] [Related]
17. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
18. Prions and the potential transmissibility of protein misfolding diseases.
Kraus A; Groveman BR; Caughey B
Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
[TBL] [Abstract][Full Text] [Related]
19. A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models.
Otero A; Hedman C; Fernández-Borges N; Eraña H; Marín B; Monzón M; Sánchez-Martín MA; Nonno R; Badiola JJ; Bolea R; Castilla J
Mol Neurobiol; 2019 Sep; 56(9):6501-6511. PubMed ID: 30847740
[TBL] [Abstract][Full Text] [Related]
20. Protein misfolding cyclic amplification of infectious prions.
Morales R; Duran-Aniotz C; Diaz-Espinoza R; Camacho MV; Soto C
Nat Protoc; 2012 Jun; 7(7):1397-409. PubMed ID: 22743831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
